Stay updated on Nivolumab with RT for Head & Neck Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:16:03.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a modification in the study plan for a Phase II clinical trial evaluating the efficacy and safety of nivolumab in combination with radiation therapy for patients with locally advanced, unresectable head and neck mucosal melanoma.
    Difference
    0.1%
    Check dated 2024-06-06T14:19:50.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying requirements such as age, health condition, and prior treatments. Previously, no information was provided about the participation criteria for collaborators and investigators.
    Difference
    38%
    Check dated 2024-05-22T20:29:30.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:17:56.000Z thumbnail image

Stay in the know with updates to Nivolumab with RT for Head & Neck Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page.